303 related articles for article (PubMed ID: 21909448)
1. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.
Tricou V; Minh NN; Farrar J; Tran HT; Simmons CP
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1309. PubMed ID: 21909448
[TBL] [Abstract][Full Text] [Related]
2. Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.
de la Cruz-Hernández SI; Flores-Aguilar H; González-Mateos S; López-Martinez I; Alpuche-Aranda C; Ludert JE; del Angel RM
Am J Trop Med Hyg; 2013 Mar; 88(3):446-54. PubMed ID: 23339203
[TBL] [Abstract][Full Text] [Related]
3. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam.
Fox A; Le NM; Simmons CP; Wolbers M; Wertheim HF; Pham TK; Tran TH; Trinh TM; Nguyen TL; Nguyen VT; Nguyen DH; Farrar J; Horby P; Taylor WR; Nguyen VK
PLoS Negl Trop Dis; 2011 Mar; 5(3):e967. PubMed ID: 21390156
[TBL] [Abstract][Full Text] [Related]
4. NS1 Antigenemia and Viraemia Load: Potential Markers of Progression to Dengue Fatal Outcome?
Nunes PCG; Nogueira RMR; Heringer M; Chouin-Carneiro T; Damasceno Dos Santos Rodrigues C; de Filippis AMB; Lima MDRQ; Dos Santos FB
Viruses; 2018 Jun; 10(6):. PubMed ID: 29903980
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status.
Duyen HT; Ngoc TV; Ha do T; Hang VT; Kieu NT; Young PR; Farrar JJ; Simmons CP; Wolbers M; Wills BA
J Infect Dis; 2011 May; 203(9):1292-300. PubMed ID: 21335562
[TBL] [Abstract][Full Text] [Related]
6. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of viremia, antigenemia and infection of circulating monocytes in children with mild and severe dengue.
Perdomo-Celis F; Salgado DM; Narváez CF
Acta Trop; 2017 Mar; 167():1-8. PubMed ID: 27986543
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.
Tricou V; Minh NN; Van TP; Lee SJ; Farrar J; Wills B; Tran HT; Simmons CP
PLoS Negl Trop Dis; 2010 Aug; 4(8):e785. PubMed ID: 20706626
[TBL] [Abstract][Full Text] [Related]
9. Co-circulation of dengue virus serotypes in Central India: Evidence of prolonged viremia in DENV-2.
Agarwal A; Gupta S; Chincholkar T; Singh V; Umare IK; Ansari K; Paliya S; Yadav AK; Chowdhary R; Purwar S; Biswas D
Infect Genet Evol; 2019 Jun; 70():72-79. PubMed ID: 30798036
[TBL] [Abstract][Full Text] [Related]
10. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity.
Duong V; Ly S; Lorn Try P; Tuiskunen A; Ong S; Chroeung N; Lundkvist A; Leparc-Goffart I; Deubel V; Vong S; Buchy P
PLoS Negl Trop Dis; 2011 Jul; 5(7):e1244. PubMed ID: 21811645
[TBL] [Abstract][Full Text] [Related]
11. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of nonstructural glycoprotein-1 in dengue patients presenting with different clinical manifestations from 1986 to 2012 in Rio de Janeiro, Brazil.
Gonçalves BS; Horta MAP; Acero PHC; Bochner R; Queiroz Lima MDR; de Araújo ES; Sampaio SA; Nogueira RMR; de Filippis AMB
J Med Virol; 2019 Apr; 91(4):555-563. PubMed ID: 30411369
[TBL] [Abstract][Full Text] [Related]
13. Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection.
Lai SC; Huang YY; Shu PY; Chang SF; Hsieh PS; Wey JJ; Tsai MH; Ben RJ; Hsu YM; Fang YC; Hsiao ML; Lin CC
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 30971466
[TBL] [Abstract][Full Text] [Related]
14. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.
Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
J Med Virol; 2000 Oct; 62(2):224-32. PubMed ID: 11002252
[TBL] [Abstract][Full Text] [Related]
15. Dengue in travelers: kinetics of viremia and NS1 antigenemia and their associations with clinical parameters.
Erra EO; Korhonen EM; Voutilainen L; Huhtamo E; Vapalahti O; Kantele A
PLoS One; 2013; 8(6):e65900. PubMed ID: 23755291
[TBL] [Abstract][Full Text] [Related]
16. Decreased peripheral dendritic cell numbers in dengue virus infection.
De Carvalho Bittencourt M; Martial J; Cabié A; Thomas L; Césaire R
J Clin Immunol; 2012 Feb; 32(1):161-72. PubMed ID: 21969208
[TBL] [Abstract][Full Text] [Related]
17. Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region.
Heringer M; Souza TMA; Lima MDRQ; Nunes PCG; Faria NRDC; de Bruycker-Nogueira F; Chouin-Carneiro T; Nogueira RMR; Dos Santos FB
BMC Infect Dis; 2017 Jun; 17(1):410. PubMed ID: 28599640
[TBL] [Abstract][Full Text] [Related]
18. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
19. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
